Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD146/HER2 CAR T cells in advanced sarcomas
NCT07066982Phase 2Recruiting
- Sponsor
- Essen BioTech
- Start
- May 2025
- Primary completion
- Dec 2027
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of BrainChild-01 in sarcoma, sponsored by Essen BioTech. Started May 2025; status: recruiting.
02
Drugs
BrainChild-01
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT07066982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07066982.